You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARRY-380

Showing 1 - 25 of 129
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)

Not yet recruiting
  • Metastatic Solid Tumor
  • Brain Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Dec 30, 2022

Colorectal Tumors Trial in United States (tucatinib, trastuzumab, bevacizumab)

Recruiting
  • Colorectal Neoplasms
  • Anaheim, California
  • +13 more
Aug 15, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Cancer Trial in Canada, United States (ARRY-380, HER2 inhibitor; oral)

Completed
  • Cancer
  • ARRY-380, HER2 inhibitor; oral
  • Aurora, Colorado
  • +3 more
May 5, 2020

HER2 Positive Breast Cancer Trial in United States (tucatinib, trastuzumab deruxtecan)

Recruiting
  • HER2 Positive Breast Cancer
  • Birmingham, Alabama
  • +32 more
Oct 26, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Oct 27, 2022

Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

Recruiting
  • Uterine Neoplasms
  • +5 more
  • Goodyear, Arizona
  • +63 more
Aug 15, 2022

HER2 Positive Breast Cancer Trial in Worldwide (Tucatinib, Trastuzumab, Pertuzumab)

Recruiting
  • HER2 Positive Breast Cancer
  • Phoenix, Arizona
  • +143 more
Jan 20, 2023

Brain Metastases, HER2-positive Breast Cancer Trial (Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

Not yet recruiting
  • Brain Metastases
  • HER2-positive Breast Cancer
  • Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine
  • (no location specified)
Jan 10, 2023

HER2 Positive Breast Cancers Trial in Canada, United States (Tucatinib (ONT-380), T-DM1)

Completed
  • HER2 Positive Breast Cancers
  • Birmingham, Alabama
  • +10 more
Sep 17, 2020

Cachexia Trial (AV-380)

Not yet recruiting
  • Cachexia
  • AV-380
  • (no location specified)
May 9, 2023

Postpartum Contraception Trial in Cairo (Copper T380 IUD ( Paragard 380 A ,CooperSurgical, Inc. © 2022) (classic technique),

Recruiting
  • Postpartum Contraception
  • Copper T380 IUD ( Paragard 380 A ,CooperSurgical, Inc. © 2022) (classic technique)
  • +2 more
  • Cairo, Egypt
    Kasr Alainy outpatient infertility clinic
Feb 23, 2023

Uterine Artery Doppler and Menstrual Changes After Insertion

Not yet recruiting
  • Intrauterine Contraceptive Device Complication
  • Copper intrauterine contraceptive device
  • LNG-IUS
  • Banī Suwayf, Beni Suef, Egypt
    Beni-suef university Hospital
Aug 13, 2023

HER2 Positive Metastatic Breast Cancers Trial in United States (Tucatinib, Capecitabine, Trastuzumab)

Completed
  • HER2 Positive Metastatic Breast Cancers
  • Aurora, Colorado
  • +4 more
Jun 2, 2020

Renal Cell Carcinoma, Melanoma, Solid Tumor Trial in Pittsburgh (Phase Ib ARRY-614 + nivolumab, Phase Ib ARRY-614 +

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Phase Ib ARRY-614 + nivolumab
  • +4 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 9, 2022

LMNA-Related Dilated Cardiomyopathy Trial in United States (ARRY-371797, p38 inhibitor, oral)

Completed
Has Results
  • LMNA-Related Dilated Cardiomyopathy
  • ARRY-371797, p38 inhibitor, oral
  • Aurora, Colorado
  • +3 more
Mar 3, 2022

Healthy Trial in Madison (PF-07265803)

Completed
  • Healthy
  • Madison, Wisconsin
    Labcorp Clinical Research Unit
Jul 10, 2022

Opioid-use Disorder Trial in New York (Naltrexone 380 MG)

Active, not recruiting
  • Opioid-use Disorder
  • Naltrexone 380 MG
  • New York, New York
    Columbia University Medical Center
Jul 1, 2022

Periodontitis, Diabetes Trial in Rawalpindi (1ml of 1% metronidazole gel, 1ml of 2% minocycline gel, 1ml of combination of 1%

Completed
  • Periodontitis
  • Diabetes Mellitus
  • 1ml of 1% metronidazole gel
  • +2 more
  • Rawalpindi, Punjab, Pakistan
    Islamic International Medical Collège, IIMC
Aug 31, 2023

IUD Trial (IUD)

Not yet recruiting
  • IUD
  • IUD
  • (no location specified)
Mar 8, 2022

Cachexia Trial in Newark (AV-380, Placebo)

Active, not recruiting
  • Cachexia
  • Newark, New Jersey
    Biotrial Inc.
Jan 18, 2022

Pulmonary Hypertension Trial in Lexington (MK-5475, Placebo)

Recruiting
  • Pulmonary Hypertension
  • Lexington, Kentucky
    Lexington VA Medical Center - Cooper Division ( Site 0137)
Jan 8, 2023

Obesity, Child Trial (sequencing of a panel of 14 genes in leptin melanocortin pathway)

Not yet recruiting
  • Obesity, Child
  • sequencing of a panel of 14 genes in leptin melanocortin pathway
  • (no location specified)
Jul 3, 2023

Trial (Tucatinib)

No longer available
    • (no location specified)
    Feb 21, 2020